T-O (am): 0.000 (08:59:00)
Last updated: 17:00
Customize
Select columns required and click "Update" to save your preferences
Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
22 Nov 24 | Q3 Sep 24 | 3 | 31 Dec 24 | 12.29 | 1.92 | 1.50 | 12.2% | 0.00 | 0.24 |
EPS | 0.74 sen |
Trailing PE (Sector Median: 25.8) | 29.7 |
PEG | 0 |
Altman Z | 0.0 |
Beaver | 0 |
Current Ratio | 0 |
Debt-Equity (DE) Ratio | 0 |
FCF Yield | 0.0 % |
Revenue QoQ | 0 % |
Revenue YoY | 0% |
Profit QoQ | 0 % |
Profit YoY | 0 % |
Profit Margin (Sector Median: 9.4) | 11.44 % |
ROE (ROIC: 0) | 0 % |
Dividend Per Share (DPS) | 0.0 sen |
Dividend Yield (DY) | 0.0 % |
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
EPS | |
Trailing PE (Sector Median: 25.8) | |
Profit QoQ | |
Profit YoY | |
Profit Margin (Sector Median: 9.4) | |
ROE | |
Altman Z |
Discounted Cash Flow (DCF) 5% Growth | |
Discounted Cash Flow (DCF) 10% Growth | |
Relative Valuation | |
Average Analysts FV based on 2 rating(s) |
Graham Formula | |
Graham Number | |
Net Tangible Asset (NTA) | 0.06 | Consistent QR FV |
Forward PE FV Calculator | |
Latest Profit (adjusted) [M] | 1.5 |
Expected Profit (Next QR) [M] | |
Expected Profit (After QR above) [M] | |
Expected Profit (After QR above) [M] | |
Estimated Fair Value |
Growth/Risk Fair Value Calculator | |
Expected growth (%) | |
Estimated downside / risk (%) | |
Estimated New DCF Fair Value |
Contract/Award Contribution Calculator | |
Contract/Award Value (in Million) | |
Estimated Contribution to Stock Price | |
Estimated New DCF Fair Value |
Profit-Based Calculator | |
Expected Profit (M) | |
for Year | |
Estimated New DCF Fair Value |
Revenue-Based Calculator | |
Expected Revenue (M) | |
for Year | |
Estimated New DCF Fair Value |
Market Pricing | |
Expected Profit (M) | 0 |
Expected Revenue (M) | 0 |
Expected Growth (%) | 0 |
No transaction in the last 2 months.
Market Cap: 215 M.
Market Cap Class: Micro caps
Number of Shares: 978 M.
Adjusted Float: 0%.
Metro Healthcare Berhad is primarily focused on providing obstetrics and gynecological (O&G) healthcare services, with a specialization in fertility treatments. The company has strategically shifted its focus to enhance its core offerings in O&G healthcare, which include comprehensive fertility services and general obstetrics and gynecological care. To complement these services, Metro Healthcare also offers pediatric services; however, it has discontinued dental and traditional Chinese medicine fertility services as of 2022 and 2023, respectively. This realignment reflects the company’s commitment to strengthening its position within the O&G healthcare sector. Metro Healthcare was incorporated in 2010 and headquartered in Klang, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0329
Website: https://www.metro.com.my/
Related Links: Bursa | Annual Report | Announcement
No warrants listed
Shareholder | % | Value (M) |
---|---|---|
Dr Tay Swi Peng @ Tee Swi Peng | 43.39% | 93.45 |
Lim Wai Khong | 0.73% | 1.56 |
Seah Cheong Wei | 0.02% | 0.04 |
Cik Rose Zilawati Binti Mohamed Arifin | 0.01% | 0.02 |
Dr Yee Meng Kheong | 0.01% | 0.02 |
Chua Leng Leek | 0.01% | 0.02 |